Spots Global Cancer Trial Database for targeted therapies
Every month we try and update this database with for targeted therapies cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors | NCT03149523 | Colorectal Aden... Hepatic Carcino... Kidney Adenocar... | 18 Years - 80 Years | European Georges Pompidou Hospital | ||
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients | NCT02139020 | Squamous Cell C... | Plasma samples | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of Recurrence | NCT05062096 | Melanoma | Blood samples Skin biopsy | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old | NCT03155217 | Metastatic Mela... | 18 Years - 110 Years | University Hospital, Montpellier | ||
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia | NCT05130138 | Chronic Myeloid... | Pharmaceutical ... | 18 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma | NCT01195922 | Mouth Neoplasms Head and Neck N... Tongue Neoplasm... Carcinoma, Squa... | Sirolimus | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metastatic Melanoma or as Adjuvant Therapy for High-risk of Recurrence | NCT05062096 | Melanoma | Blood samples Skin biopsy | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old | NCT03155217 | Metastatic Mela... | 18 Years - 110 Years | University Hospital, Montpellier | ||
Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors | NCT03149523 | Colorectal Aden... Hepatic Carcino... Kidney Adenocar... | 18 Years - 80 Years | European Georges Pompidou Hospital | ||
Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia | NCT05130138 | Chronic Myeloid... | Pharmaceutical ... | 18 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma | NCT01195922 | Mouth Neoplasms Head and Neck N... Tongue Neoplasm... Carcinoma, Squa... | Sirolimus | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) |